Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma, B-Cell × daratumumab × Clear all

Sponsor

Conditions

Multiple Myeloma 35 Leukemia, Myeloid, Acute 4 Recurrence 3 Waldenstrom Macroglobulinemia 2 Immunoglobulin Light-chain Amyloidosis 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Plasmacytoma 1 Pancreatic Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Microsatellite Unstable Colorectal Cancer 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma 1 Leukemia, Myeloid 1 Leukemia, Monocytic, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hypergammaglobulinemia 1 Hodgkin Disease 1

Interventions

Rituximab 34 Cyclophosphamide 24 Etoposide 12 Doxorubicin 12 Vincristine 11 Prednisone 11 ibrutinib 9 fludarabine 8 fludarabine phosphate 7 Mycophenolic Acid 5 Inotuzumab Ozogamicin 5 Cytarabine 5 pembrolizumab 4 Peripheral Blood Stem Cell Transplantation 4 Lenalidomide 4 Carmustine 4 CT-P10 4 Brentuximab Vedotin 4 Bortezomib 4 tositumomab I-131 3 tazemetostat 3 obinutuzumab 3 Prednisolone 3 Methylprednisolone 3 Melphalan 3 Ifosfamide 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Diphenhydramine 3 Cyclosporine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡